BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abbas G, Krasna M. Overview of esophageal cancer. Ann Cardiothorac Surg. 2017;6:131-136. [PMID: 28447001 DOI: 10.21037/acs.2017.03.03] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 11.2] [Reference Citation Analysis]
Number Citing Articles
1 de Vegt F, Gommers JJJ, Groenewoud H, Siersema PD, Verbeek ALM, Peters Y, Broeders MJM. Trends and projections in the incidence of oesophageal cancer in the Netherlands: An age-period-cohort analysis from 1989 to 2041. Int J Cancer 2022;150:420-30. [PMID: 34605022 DOI: 10.1002/ijc.33836] [Reference Citation Analysis]
2 Chetwood JD, Garg P, Finch P, Gordon M. Systematic review: the etiology of esophageal squamous cell carcinoma in low-income settings. Expert Review of Gastroenterology & Hepatology 2018;13:71-88. [DOI: 10.1080/17474124.2019.1543024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Coelho FDS, Barros DE, Santos FA, Meireles FC, Maia FC, Trovisco RA, Machado TM, Barbosa JA. Minimally invasive esophagectomy versus open esophagectomy: A systematic review and meta-analysis. Eur J Surg Oncol 2021:S0748-7983(21)00575-8. [PMID: 34148823 DOI: 10.1016/j.ejso.2021.06.012] [Reference Citation Analysis]
4 Giordo R, Wehbe Z, Paliogiannis P, Eid AH, Mangoni AA, Pintus G. Nano-targeting vascular remodeling in cancer: Recent developments and future directions. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.03.001] [Reference Citation Analysis]
5 Nguyen HT, Kacimi SEO, Nguyen TL, Suman KH, Lemus-Martin R, Saleem H, Do DN. MiR-21 in the Cancers of the Digestive System and Its Potential Role as a Diagnostic, Predictive, and Therapeutic Biomarker. Biology (Basel) 2021;10:417. [PMID: 34066762 DOI: 10.3390/biology10050417] [Reference Citation Analysis]
6 Yu R, Wang W, Li T, Li J, Zhao K, Wang W, Liang L, Wu H, Ai T, Huang W, Li L, Yu W, Wei C, Wang Y, Shen W, Xiao Z. RATIONALE 311: tislelizumab plus concurrent chemoradiotherapy for localized esophageal squamous cell carcinoma. Future Oncol 2021. [PMID: 34269067 DOI: 10.2217/fon-2021-0632] [Reference Citation Analysis]
7 Barrientos-Robledo SG, Cebada-Ruiz JA, Rodríguez-Alba JC, Baltierra-Uribe SL, Díaz Y Orea MA, Romero-Ramírez H. CD38 a biomarker and therapeutic target in non-hematopoietic tumors. Biomark Med 2022. [PMID: 35195042 DOI: 10.2217/bmm-2021-0575] [Reference Citation Analysis]
8 Kwak AW, Lee MH, Yoon G, Cho SS, Choi JS, Chae JI, Shim JH. Deoxypodophyllotoxin, a Lignan from Anthriscus sylvestris, Induces Apoptosis and Cell Cycle Arrest by Inhibiting the EGFR Signaling Pathways in Esophageal Squamous Cell Carcinoma Cells. Int J Mol Sci 2020;21:E6854. [PMID: 32961992 DOI: 10.3390/ijms21186854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Xue Y, Chen D, Wang W, Wang W, Chen L, Sang Y, Chen Y, Xu W. Comparison of Ivor Lewis and Sweet esophagectomy for middle and lower esophageal squamous cell carcinoma: A systematic review and pooled analysis. EClinicalMedicine 2020;27:100497. [PMID: 33089129 DOI: 10.1016/j.eclinm.2020.100497] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Zang R, Qiu X, Song Y, Wang Y. Exosomes Mediated Transfer of Circ_0000337 Contributes to Cisplatin (CDDP) Resistance of Esophageal Cancer by Regulating JAK2 via miR-377-3p. Front Cell Dev Biol 2021;9:673237. [PMID: 34307356 DOI: 10.3389/fcell.2021.673237] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Yang PW, Lin MC, Huang PM, Wang CP, Chen TC, Chen CN, Tsai MH, Cheng JC, Chuang EY, Hsieh MS, Lou PJ, Lee JM. Risk Factors and Genetic Biomarkers of Multiple Primary Cancers in Esophageal Cancer Patients. Front Oncol 2020;10:585621. [PMID: 33552962 DOI: 10.3389/fonc.2020.585621] [Reference Citation Analysis]
12 Baiu I, Titan AL, Martin LW, Wolf A, Backhus L. The role of gender in non-small cell lung cancer: a narrative review. J Thorac Dis 2021;13:3816-26. [PMID: 34277072 DOI: 10.21037/jtd-20-3128] [Reference Citation Analysis]
13 Ebigbo A, Römmele C, Meisinger C, Probst A, Beyer A, Arnold J, Beer F, Endlicher E, Schiffelholz W, Linseisen J, Messmann H. [Screening gastroscopy in Germany - first results of the pilot phase of the Prä-GIT study]. Z Gastroenterol 2020;58:761-6. [PMID: 32572870 DOI: 10.1055/a-1190-5332] [Reference Citation Analysis]
14 Wang X, Hobbs B, Gandhi SJ, Muijs CT, Langendijk JA, Lin SH. Current status and application of proton therapy for esophageal cancer. Radiother Oncol 2021;164:27-36. [PMID: 34534613 DOI: 10.1016/j.radonc.2021.09.004] [Reference Citation Analysis]
15 Kooshkaki O, Derakhshani A, Hosseinkhani N, Torabi M, Safaei S, Brunetti O, Racanelli V, Silvestris N, Baradaran B. Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials. Int J Mol Sci 2020;21:E4427. [PMID: 32580338 DOI: 10.3390/ijms21124427] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
16 Whitsett TG, Mittal SK, Eschbacher JM, Carson VM, Smith MA, Bremner RM, Inge LJ. LKB1 inactivation occurs in a subset of esophageal adenocarcinomas and is sufficient to drive tumor cell proliferation. J Thorac Cardiovasc Surg 2018;155:1891-9. [PMID: 29370903 DOI: 10.1016/j.jtcvs.2017.11.067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Costa NR, Gil da Costa RM, Medeiros R. A viral map of gastrointestinal cancers. Life Sci 2018;199:188-200. [PMID: 29476768 DOI: 10.1016/j.lfs.2018.02.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
18 Zhao G, Li H, Guo Q, Zhou A, Wang X, Li P, Zhang S. Exosomal Sonic Hedgehog derived from cancer-associated fibroblasts promotes proliferation and migration of esophageal squamous cell carcinoma. Cancer Med 2020;9:2500-13. [PMID: 32030915 DOI: 10.1002/cam4.2873] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
19 Shao Y, Chen D, Ye L, Wang XM, Wu QC, Zhang C. Survival benefit of perioperative chemotherapy for T1-3N0M0 stage esophageal cancer: a SEER database analysis. J Thorac Dis 2021;13:995-1004. [PMID: 33717572 DOI: 10.21037/jtd-20-2877] [Reference Citation Analysis]
20 Ahmadinejad M, Hashemi M, Tabatabai A. A Comparative Study between the Postoperative Complications of Stripping Esophagectomy and Classic (Orringer's Technique) Esophagectomy. Surg J (N Y) 2022;8:e34-40. [PMID: 35128051 DOI: 10.1055/s-0041-1736666] [Reference Citation Analysis]
21 Banda K, Chiu H, Hu SH, Yeh H, Lin K, Huang H. Associations of dietary carbohydrate and salt consumption with esophageal cancer risk: a systematic review and meta-analysis of observational studies. Nutrition Reviews 2020;78:688-98. [DOI: 10.1093/nutrit/nuz097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Sun Y, Qiu L, Chen J, Wang Y, Qian J, Huang L, Ma H. Construction of circRNA-Associated ceRNA Network Reveals Novel Biomarkers for Esophageal Cancer. Comput Math Methods Med 2020;2020:7958362. [PMID: 32908582 DOI: 10.1155/2020/7958362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Wang F, Zhang L, Xu Y, Xie Y, Li S. Comprehensive Analysis and Identification of Key Driver Genes for Distinguishing Between Esophageal Adenocarcinoma and Squamous Cell Carcinoma. Front Cell Dev Biol 2021;9:676156. [PMID: 34124063 DOI: 10.3389/fcell.2021.676156] [Reference Citation Analysis]
24 Jezerskyte E, van Berge Henegouwen MI, Cuesta MA, Gisbertz SS. Gastro-esophageal junction cancers: what is the best minimally invasive approach? J Thorac Dis 2017;9:S751-60. [PMID: 28815071 DOI: 10.21037/jtd.2017.06.56] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
25 Melo AM, Conroy MJ, Foley EK, Dockry É, Breen EP, Reynolds JV, Lysaght J, Doherty DG. CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies. Cancer Immunol Immunother 2020;69:969-82. [DOI: 10.1007/s00262-020-02514-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Xue XJ, Li FR, Yu J. Mitochondrial pathway of the lysine demethylase 5C inhibitor CPI-455 in the Eca-109 esophageal squamous cell carcinoma cell line. World J Gastroenterol 2021; 27(16): 1805-1815 [PMID: 33967558 DOI: 10.3748/wjg.v27.i16.1805] [Reference Citation Analysis]
27 Yin X, Zhang P, Xia N, Wu S, Liu B, Weng L, Shang M. GPx8 regulates apoptosis and autophagy in esophageal squamous cell carcinoma through the IRE1/JNK pathway. Cellular Signalling 2022. [DOI: 10.1016/j.cellsig.2022.110307] [Reference Citation Analysis]
28 Papaconstantinou D, Tsilimigras DI, Moris D, Michalinos A, Mastoraki A, Mpaili E, Hasemaki N, Bakopoulos A, Filippou D, Schizas D. Synchronous resection of esophageal cancer and other organ malignancies: A systematic review. World J Gastroenterol 2019; 25(26): 3438-3449 [PMID: 31341367 DOI: 10.3748/wjg.v25.i26.3438] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Lu T, Wang R, Cai H, Cui Y. Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p/E2F7 axis. Biomedicine & Pharmacotherapy 2020;123:109650. [DOI: 10.1016/j.biopha.2019.109650] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
30 Zhang J, Xiao F, Qiang G, Zhang Z, Ma Q, Hao Y, Xing H, Liang C. Novel lncRNA Panel as for Prognosis in Esophageal Squamous Cell Carcinoma Based on ceRNA Network Mechanism. Comput Math Methods Med 2021;2021:8020879. [PMID: 34603485 DOI: 10.1155/2021/8020879] [Reference Citation Analysis]
31 Macedo-Silva C, Miranda-Gonçalves V, Lameirinhas A, Lencart J, Pereira A, Lobo J, Guimarães R, Martins AT, Henrique R, Bravo I, Jerónimo C. JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma. Cell Death Dis 2020;11:1068. [PMID: 33318475 DOI: 10.1038/s41419-020-03279-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Sawas T, Manrique GC, Iyer PG, Wang KK, Katzka DA. Young Adults With Esophageal Adenocarcinoma Present With More Advanced Stage Tumors and Have Shorter Survival Times. Clin Gastroenterol Hepatol 2019;17:1756-62. [PMID: 30267861 DOI: 10.1016/j.cgh.2018.09.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
33 Xiang Z, Hua M, Hao Z, Biao H, Zhu C, Zhai G, Wu J. The Roles of Mesenchymal Stem Cells in Gastrointestinal Cancers. Front Immunol 2022;13:844001. [PMID: 35281017 DOI: 10.3389/fimmu.2022.844001] [Reference Citation Analysis]
34 Chen C, Wang W, Hsu M, Mochly-rosen D. Alcohol Consumption, ALDH2 Polymorphism as Risk Factors for Upper Aerodigestive Tract Cancer Progression and Prognosis. Life 2022;12:348. [DOI: 10.3390/life12030348] [Reference Citation Analysis]
35 Dahiya DS, Kichloo A, Singh J, Albosta M, Lekkala M. Current immunotherapy in gastrointestinal malignancies A Review. J Investig Med 2021;69:689-96. [PMID: 33443046 DOI: 10.1136/jim-2020-001654] [Reference Citation Analysis]
36 Liu Y, Wang X, Jiang X, Yan P, Zhan L, Zhu H, Wang T, Wen J. Tumor-suppressive microRNA-10a inhibits cell proliferation and metastasis by targeting Tiam1 in esophageal squamous cell carcinoma. J Cell Biochem 2018. [PMID: 30426564 DOI: 10.1002/jcb.28059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
37 Almatroudi A. The Incidence Rate of Esophageal Cancer in Saudi Arabia: An Observational and a Descriptive Epidemiological Analyses. Front Public Health 2022;10:818691. [DOI: 10.3389/fpubh.2022.818691] [Reference Citation Analysis]
38 Midthun L, Kim S, Hendifar A, Osipov A, Klempner SJ, Chao J, Cho M, Guan M, Placencio-Hickok VR, Gangi A, Burch M, Lin DC, Waters K, Atkins K, Kamrava M, Gong J. Chemotherapy predictors and a time-dependent chemotherapy effect in metastatic esophageal cancer. World J Gastrointest Oncol 2022; 14(2): 511-524 [DOI: 10.4251/wjgo.v14.i2.511] [Reference Citation Analysis]
39 Salta S, Macedo-Silva C, Miranda-Gonçalves V, Lopes N, Gigliano D, Guimarães R, Farinha M, Sousa O, Henrique R, Jerónimo C. A DNA methylation-based test for esophageal cancer detection. Biomark Res 2020;8:68. [PMID: 33292587 DOI: 10.1186/s40364-020-00248-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Zhu P, Huang H, Gu S, Liu Z, Zhang X, Wu K, Lu T, Li L, Dong C, Zhong C, Zhou Y. Long Noncoding RNA FAM225A Promotes Esophageal Squamous Cell Carcinoma Development and Progression via Sponging MicroRNA-197-5p and Upregulating NONO. J Cancer 2021;12:1073-84. [PMID: 33442405 DOI: 10.7150/jca.51292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Rasic P, Jovanovic-Tucovic M, Jeremic M, Djuricic SM, Vasiljevic ZV, Milickovic M, Savic D. B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors. World J Gastrointest Oncol 2021; 13(8): 799-821 [PMID: 34457187 DOI: 10.4251/wjgo.v13.i8.799] [Reference Citation Analysis]
42 Zare M, Hadi F, Alivand MR. Considering the downregulation of Tpm1.6 and Tpm1.7 in squamous cell carcinoma of esophagus as a potent biomarker. Per Med 2018;15:361-70. [PMID: 30259780 DOI: 10.2217/pme-2018-0015] [Reference Citation Analysis]
43 Naeli P, Pourhanifeh MH, Karimzadeh MR, Shabaninejad Z, Movahedpour A, Tarrahimofrad H, Mirzaei HR, Bafrani HH, Savardashtaki A, Mirzaei H, Hamblin MR. Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role. Crit Rev Oncol Hematol 2020;145:102854. [PMID: 31877535 DOI: 10.1016/j.critrevonc.2019.102854] [Cited by in Crossref: 83] [Cited by in F6Publishing: 85] [Article Influence: 27.7] [Reference Citation Analysis]
44 Rozeboom PD, Dyas AR, Bronsert MR, Bhagat R, Meguid RA. Improving postoperative outcomes in esophagectomy for cancer-what is the role of institutional data? J Thorac Dis 2020;12:1750-3. [PMID: 32642077 DOI: 10.21037/jtd-20-1681] [Reference Citation Analysis]
45 Siddiqui AZ, Almhanna K. Beyond Chemotherapy, PD-1, and HER-2: Novel Targets for Gastric and Esophageal Cancer. Cancers (Basel) 2021;13:4322. [PMID: 34503132 DOI: 10.3390/cancers13174322] [Reference Citation Analysis]
46 Sharma B, Raina S, Sharma R, Bodh V, Raina SK, Sharma N. Self-Expanding Metallic Stents (SEMS) in Inoperable Esophageal Cancer: A Prospective Analysis of Morbidity and Survival Outcomes. Indian J Palliat Care 2019;25:398-402. [PMID: 31413455 DOI: 10.4103/IJPC.IJPC_185_18] [Reference Citation Analysis]
47 Xia TL, Yan SM, Yuan L, Zeng MS. Upregulation of METTL3 Expression Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2020;12:5729-37. [PMID: 32765076 DOI: 10.2147/CMAR.S245019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
48 Jin YQ, Miao DL. Multiomic Analysis of Methylation and Transcriptome Reveals a Novel Signature in Esophageal Cancer. Dose Response 2020;18:1559325820942075. [PMID: 32728353 DOI: 10.1177/1559325820942075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Li J, Mei X, Sun D, Guo M, Xie M, Chen X. A Nutrition and Inflammation-Related Nomogram to Predict Overall Survival in Surgically Resected Esophageal Squamous Cell Carcinoma (ESCC) Patients. Nutr Cancer 2021;:1-11. [PMID: 34369223 DOI: 10.1080/01635581.2021.1957131] [Reference Citation Analysis]
50 Wondimagegnehu A, Hirpa S, Abaya SW, Gizaw M, Getachew S, Ayele W, Yirgu R, Demeke T, Dessalegn B, Diribi J, Kaba M, Assefa M, Jemal A, Kantelhardt EJ, Addissie A. Oesophageal cancer magnitude and presentation in Ethiopia 2012-2017. PLoS One 2020;15:e0242807. [PMID: 33259514 DOI: 10.1371/journal.pone.0242807] [Reference Citation Analysis]
51 Peng J, Shi S, Yu J, Liu J, Wei H, Song H, Wang S, Li Z, He S, Li L, Zhang H, Yan Z, Zhao R, Liu Y, Liu Y, Li J, Zhang R, Wang W. miR-378d suppresses malignant phenotype of ESCC cells through AKT signaling. Cancer Cell Int 2021;21. [DOI: 10.1186/s12935-021-02403-y] [Reference Citation Analysis]
52 Chen Z, Shen Z, Zhang Z, Zhao D, Xu L, Zhang L. RNA-Associated Co-expression Network Identifies Novel Biomarkers for Digestive System Cancer. Front Genet 2021;12:659788. [PMID: 33841514 DOI: 10.3389/fgene.2021.659788] [Reference Citation Analysis]
53 Guo J, Wang Z, Qin J, Zhang H, Liu W, Zhao Y, Lu Y, Yan X, Zhang Z, Zhang T, Zhang S, Dominik NM, Kamel IR, Li H, Qu J. A prospective analysis of the diagnostic accuracy of 3 T MRI, CT and endoscopic ultrasound for preoperative T staging of potentially resectable esophageal cancer. Cancer Imaging 2020;20:64. [PMID: 32912319 DOI: 10.1186/s40644-020-00343-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Shen L, Guo J, Zhang Q, Pan H, Yuan Y, Bai Y, Liu T, Zhou Q, Zhao J, Shu Y, Huang X, Wang S, Wang J, Zhou A, Ye D, Sun T, Gao Y, Yang S, Wang Z, Li J, Wu YL. Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study. J Immunother Cancer 2020;8:e000437. [PMID: 32561638 DOI: 10.1136/jitc-2019-000437] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
55 Amjadi I, Mohajeri M, Borisov A, Hosseini MS. Antiproliferative Effects of Free and Encapsulated Hypericum Perforatum L. Extract and Its Potential Interaction with Doxorubicin for Esophageal Squamous Cell Carcinoma. J Pharmacopuncture 2019;22:102-8. [PMID: 31338250 DOI: 10.3831/KPI.2019.22.013] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
56 Zhang X, Lu N, Wang L, Wang Y, Li M, Zhou Y, Cui M, Zhang M, Zhang L. Recent advances of m6A methylation modification in esophageal squamous cell carcinoma. Cancer Cell Int 2021;21:421. [PMID: 34376206 DOI: 10.1186/s12935-021-02132-2] [Reference Citation Analysis]
57 Wen L, Mao W, Xu L, Cai B, Gu L. Sesamin exerts anti-tumor activity in esophageal squamous cell carcinoma via inhibition of TRIM44 and NF-κB signaling. Chem Biol Drug Des 2021. [PMID: 34411455 DOI: 10.1111/cbdd.13937] [Reference Citation Analysis]
58 Parama D, Boruah M, Yachna K, Rana V, Banik K, Harsha C, Thakur KK, Dutta U, Arya A, Mao X, Ahn KS, Kunnumakkara AB. Diosgenin, a steroidal saponin, and its analogs: Effective therapies against different chronic diseases. Life Sci 2020;260:118182. [PMID: 32781063 DOI: 10.1016/j.lfs.2020.118182] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
59 Fei Z, Gu W, Xie R, Su H, Jiang Y. Artesunate enhances radiosensitivity of esophageal cancer cells by inhibiting the repair of DNA damage. J Pharmacol Sci 2018;138:131-7. [PMID: 30337244 DOI: 10.1016/j.jphs.2018.09.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
60 Wang J, Wei N, Jiang N, Lu Y, Zhang X. Comparison of Ivor-Lewis versus Sweet procedure for middle and lower thoracic esophageal squamous cell carcinoma: A STROBE compliant study. Medicine (Baltimore) 2019;98:e14416. [PMID: 30732195 DOI: 10.1097/MD.0000000000014416] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
61 Ebigbo A, Messmann H, Römmele C. Endoscopic Upper GI Screening. Visc Med 2019;35:240-4. [PMID: 31602385 DOI: 10.1159/000501889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
62 Zhang X, Lu N, Wang L, Wang Y, Li M, Zhou Y, Yan H, Cui M, Zhang M, Zhang L. Circular RNAs and esophageal cancer. Cancer Cell Int 2020;20:362. [PMID: 32774156 DOI: 10.1186/s12935-020-01451-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
63 Puhr HC, Preusser M, Ilhan-Mutlu A. Immunotherapy for Esophageal Cancers: What Is Practice Changing in 2021? Cancers (Basel) 2021;13:4632. [PMID: 34572859 DOI: 10.3390/cancers13184632] [Reference Citation Analysis]
64 Azees PAA, Natarajan S, Amaechi BT, Thajuddin N, Raghavendra VB, Brindhadevi K, Pugazhendhi A. An empirical review on the risk factors, therapeutic strategies and materials at nanoscale for the treatment of oral malignancies. Process Biochemistry 2022. [DOI: 10.1016/j.procbio.2022.04.013] [Reference Citation Analysis]
65 Chang CC, Bi KW, Lin HJ, Su YC, Wang WL, Lin CY, Ting CF, Sun MF, Huang ST. Conventional Western Treatment Associated With Chinese Herbal Medicine Ameliorates the Incidence of Head and Neck Cancer Among Patients With Esophageal Cancer. Integr Cancer Ther 2019;18:1534735419834353. [PMID: 30866690 DOI: 10.1177/1534735419834353] [Reference Citation Analysis]
66 Buckley AM, Bibby BA, Dunne MR, Kennedy SA, Davern MB, Kennedy BN, Maher SG, O'Sullivan J. Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells. Pharmaceuticals (Basel) 2019;12:E33. [PMID: 30791601 DOI: 10.3390/ph12010033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
67 Hu T, Zhang J, Sha B, Li M, Wang L, Zhang Y, Liu X, Dong Z, Liu Z, Li P, Chen P. Targeting the overexpressed USP7 inhibits esophageal squamous cell carcinoma cell growth by inducing NOXA-mediated apoptosis. Mol Carcinog 2019;58:42-54. [PMID: 30182448 DOI: 10.1002/mc.22905] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
68 Zhu Q, Huang L, Yang Q, Ao Z, Yang R, Krzesniak J, Lou D, Hu L, Dai X, Guo F, Liu F. Metabolomic analysis of exosomal-markers in esophageal squamous cell carcinoma. Nanoscale 2021;13:16457-64. [PMID: 34648610 DOI: 10.1039/d1nr04015d] [Reference Citation Analysis]
69 Gironda DJ, Adams DL, He J, Xu T, Gao H, Qiao Y, Komaki R, Reuben JM, Liao Z, Blum-Murphy M, Hofstetter WL, Tang CM, Lin SH. Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy. J Transl Med 2020;18:413. [PMID: 33148307 DOI: 10.1186/s12967-020-02563-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
70 Min YK, Baek S, Kang EK, Nam SJ. Characteristics of Patients With Esophageal Dysphagia Assessed by Chest X-Ray Imaging After Videofluoroscopic Swallowing Study. Ann Rehabil Med 2020;44:38-47. [PMID: 32130837 DOI: 10.5535/arm.2020.44.1.38] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]